Page 2 - Johnson & Johnson's

J&J says still in talks with Indian govt on Covid-19 vaccine

India had, in May, scrapped local trials for 'well-established' foreign coronavirus vaccines as it tried to hasten vaccination rollouts to fight a second wave of infections.

World Coronavirus Dispatch: Europe's soccer giants feel Covid pinch

Japan's daily cases top 10,000 for the first time, Most South Africans don't want Covid shot, and other pandemic-related news across the globe

US Supreme Court rebuffs J&J appeal over $2 billion baby powder judgement

WASHINGTON (Reuters) - The U.S. Supreme Court on Tuesday declined to hear Johnson & Johnson's bid to overturn a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in the company's baby powder and other talc products.

J&J, African Union in deal for up to 400 million Covid vaccine doses

The virus has killed almost 121,000 people across Africa and infected 4.18 million

Merck to help make J&J's coronavirus vaccine: White House official

The deal with J&J comes just days after the US government authorized its one-dose Covid-19 vaccine and as the company looks to increase its production

AstraZeneca resumes US Covid-19 vaccine trial, optimism seen for J&J

AstraZeneca's US trial was paused on September 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial

US to pay over $1 bn for 100 mn doses of J&J's potential Covid-19 vaccine

J&J has already received $1 billion in funding from the US

US Judge reduces J&J Opioid fine after mistaking thousands for millions

The miscalculation came when he was assessing various costs to the state to deal with addiction and prevention issues stemming from opioids

J&J's own expert working for FDA found asbestos in baby powder sample

(Reuters) - Ever since Johnson & Johnson disclosed this month that a government test had turned up asbestos in its Baby Powder, the company has attacked the validity of the result.

J&J to record $700-mn impairment charge related to abandoned drug program

J&J had recorded a partial impairment charge of about $630 million related to the treatment in the third quarter last year after having suspended trials in August.

Johnson & Johnson loses $70M to woman in lawsuit against baby powder

A lawsuit was filed on September 26 accusing the company of "negligent conduct" in making and marketing its baby powder